Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
EXELTIS USA DERMATOLOGY, INC. v. ACELLA PHARMACEUTICALS, LLC
Case Number:
2:15-cv-07446
Court:
Nature of Suit:
Judge:
Firms
-
August 11, 2016
Acella Escapes Skin Disorder Drugs Trade Secrets Suit
A New Jersey federal judge on Thursday dismissed Exeltis USA Dermatology Inc.’s trade secrets infringement and unfair competition suit against Acella Pharmaceuticals LLC, concluding that Exeltis failed to explain which proprietary information was taken regarding its skin disorder treatments Salvax and Hydro 35.
-
October 14, 2015
Exeltis Sues Acella Over Alleged Drug Trade Secrets Theft
Exeltis USA Dermatology Inc. on Tuesday brought a trade secret infringement and unfair competition lawsuit against Acella Pharmaceuticals LLC in New Jersey federal court, claiming its competitor improperly acquired, disclosed and used proprietary information for its Salvax and Hydro 35 products.